Brevan Howard Capital Management LP

Q2 2016 13F Holdings Report, Stock Holdings

Signature - Title
Nigel Lawrence - Authorised Signatory
Location
St. Helier, Jersey
Holdings as of
30 Jun 2016
Value $
$35,236,000
Num holdings
3
Filing time
15 Aug 2016, 16:14:19 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included EEM, CME, and OCN.
Previous filing
Q1 2016 - 16 May 2016
Next filing
Q3 2016 - 14 Nov 2016
SEC
View on sec.gov
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2016 Q2 compared to 2016 Q1 by default. Changes are calculated vs the previous SEC filing.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Nigel Lawrence Authorised Signatory St. Helier, Jersey 15 Aug 2016

*NOTE: THE INVESTMENT MANAGER FILING THIS REPORT IS DEEMED TO HAVE INVESTMENT DISCRETION WITH RESPECT TO SECURITIES OVER WHICH BREVAN HOWARD (HONG KONG) LIMITED ("BHHK"), BREVAN HOWARD INVESTMENT PRODUCTS LIMITED ("BHIPL"), BREVAN HOWARD ASSET MANAGEMENT LLP ("BHAM"), BREVAN HOWARD US INVESTMENT MANAGEMENT LP ("BHUS"), AND BREVAN HOWARD (ISRAEL) LTD. ("BH ISRAEL"), SUBSIDIARIES OF THE INVESTMENT MANAGER, EXERCISE INVESTMENT DISCRETION AS A RESULT OF THE INVESTMENT MANAGER HAVING CONTROL OVER BHHK, BHIPL, BHAM, BHUS, AND BH ISRAEL.